Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by fredgoodwinson


V.TLT

RE:RE:RE:Float, let's wait for the data now.

Thanks Science First - that makes sense.

March 10, 2022

V.TLT

RE:Pressure on stock price.................

It was ever thus. It will all come down to the Clinic.

March 7, 2022

V.TLT

RE:Newsletter Timing

Yes Eog maybe not a good idea to include the Clinical Trial results with the...

March 2, 2022

V.TLT

RE:RE:RE:RE:RE:The objective of the newsletter

No that makes sense 99942 but this whole Newsletter thing is entirely self...

March 2, 2022

V.TLT

RE:RE:RE:The objective of the newsletter

That`s right Science First there`s no requirement for financial data to...

March 2, 2022

V.TLT

RE:The objective of the newsletter

A Company is required to release price-sensitive information in a timely...

March 2, 2022

V.TLT

RE:RE:RE:RE:Regarding quarterly reports

  The Directors of an ASX-Quoted Company are obliged to present...

March 2, 2022

V.TLT

RE:RE:Commercialization Timeline Change

Yes skys1 - Vera`s appointment was transformational for the Company and her...

February 18, 2022

V.TLT

RE:RE:RE:RE:I see that the big bad BEAR just----threw--

Well I suppose it`s better than .12 not so long ago!

February 17, 2022

V.TLT

RE:RE:RE:RE:RE:BTD

Likewise appreciate the courtesy 99942. In fact there were the two topics...

February 16, 2022

V.TLT

RE:RE:RE:BTD

The way I read it was 'injectable Rutherrin still in development'...

February 16, 2022

V.TLT

RE:BTD

Tend to agree that it was that blue blob of BTD right at the end of 2022 that...

February 16, 2022

V.TLT

RE:RE:RE:RE:RE:RE:Immunity bio doing well

Thanks for that article CS - some impressive figures and likely with the use...

February 15, 2022

V.TLT

RE:been here for years and not moving yet

Agree Impala/knoxt - low-key presentation (no GBM??) and a few jitters on a...

February 15, 2022

V.TLT

RE:RE:RE:RE:Immunity bio doing well

Immunity Bio`s results are impressive but treatment looks to involve 2 x...

February 15, 2022

V.TLT

RE:RE:RE:RE:RE:TLT Filling Up With Cash

Like to say a big 'Thank you' to the Market Makers for filling the...

February 8, 2022

V.TLT

RE:Where does Theralase rank in Moon shot

Don’t recognise this binary ‘apocalypse now’ competition with immunotherapy...

February 3, 2022

V.TLT

RE:UTA article on Dr. McFarland's latest research paper

Thanks again Eog - glad that the word 'Ruthenium' was front and...

February 2, 2022

V.TLT

RE:The flaw with TLT

Subtle as a brick - but interesting to see the re-appearance of naked bashing...

February 2, 2022

V.TLT

RE:RE:RE:Level ll Quote

Thanks for taking the trouble knoxt.

February 1, 2022